Evaluation of pharmacists’ interventions on drug-related problems and drug costs in patients with cancer pain
- 24 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Pharmacy
- Vol. 43 (5), 1274-1282
- https://doi.org/10.1007/s11096-021-01247-w
Abstract
Background Drug-related problems (DRPs) prevent patients from fully benefiting from drug treatment. Unrelieved pain in patients with cancer is still widespread. Pharmacists can play a role in closely monitoring cancer patients, pain control maintenance, and patient consultation. Objective To evaluate the clinical effects and changes in drug costs of pharmacists’ interventions on patients with DRPs related to cancer pain. Setting An academic teaching hospital in Shanghai, China. Methods Patients with cancer pain admitted to Shanghai Tongren Hospital from October 2018 to February 2019 were randomized into the intervention and control groups. The Pharmaceutical Care Network Europe classification V8.02 was used to categorize DRPs treated with analgesics. Patients’ pain relief, the occurrence of adverse drug reactions, and drug cost-saving through the resolution of DRPs were evaluated. Main outcome measure Problems and causes of drug-related problems, interventions proposed, and outcome of pharmacy recommendations. Results A total of 172 patients were enrolled and randomized into the intervention group (n = 86) and the control group (n = 86). The pharmacist detected 66 DRPs in 48 patients (55.8%) of the intervention group, an average of 0.8 DRPs per patient. A total of 149 interventions were proposed by the pharmacist. Compared to the control group, the drug intervention produced more pain relief on the third day of analgesic treatment. In the intervention group, a total of 33 DRP interventions resulted in cost changes, saving a drug cost of $489.90, averaging $11.94 per intervention. Conclusion Our study suggests that pharmacy service in patients with cancer pain can resolve drug-related problems and reduce drug costs.Keywords
Funding Information
- School of Medicine, Shanghai Jiao Tong University (JDYX2017ZD005)
This publication has 16 references indexed in Scilit:
- Collaborative practice model for management of pain in patients with cancerAmerican Journal of Health-System Pharmacy, 2016
- Activities of palliative care and pain management clinical pharmacistsAmerican Journal of Health-System Pharmacy, 2015
- Pharmacists' roles in cancer pain control: A model in developing ChinaResearch in Social and Administrative Pharmacy, 2015
- Impact of a Clinical Pharmacist-Led Guidance Team on Cancer Pain Therapy in China: A Prospective Multicenter Cohort StudyJournal of Pain and Symptom Management, 2014
- Community Pharmacists' Attitudes Toward Palliative Care: An Australian Nationwide SurveyJournal of Palliative Medicine, 2013
- Pharmacist-led medication education in cancer pain control: A multicentre randomized controlled study in Guangzhou, ChinaJournal of International Medical Research, 2013
- Impact of pharmacist's interventions on cost of drug therapy in intensive care unitPharmacy Practice (Internet), 2009
- Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problemsJournal of Clinical Pharmacy & Therapeutics, 2009
- Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University HospitalPharmacy World & Science, 2008
- A Prospective, Randomized Trial to Assess the Cost Impact of Pharmacist-Initiated InterventionsArchives of Internal Medicine, 1999